EUCTR2008-003966-25-DE进行中（未招募）不适用
Double-blind, placebo controlled, randomised, monocenter cross-over studie to evaluate the effect of Desmopressin on the nocturnal polyuria in patients with idiopathic Parkinson Syndrome compared to placebo. - DEPOPA
niversität Mainz, Klinik und Poliklinik für Neurologie0 个研究点目标入组 20 人开始时间: 2008年11月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Male patients with idiopathic Parkinson Syndrome
- •18 bis 85 years
- •nocturnal Pollakisuria > 2 mictions /night (documented in Screening phase )
- •Na+ i.S > 135 mmol/l
- •Patient is able to understand all aspects and individual consequences of the clinical trial
- •An informed consent signed and dated by the patient is available prior to any study specific treatment
- •The study is consistant with the patients´ request for an appropriate treatment
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •forbidden concomitant medication (see protocol, chapter 4.2)
- •central Diabetes insipidus
- •Known heart insufficiency (NYHA Stad. III und IV)
- •clinical relevant kidney insufficiency
- •Habitual and psychogene Polydipsia
- •Hypersensitivity or allergy against the trial medication or any other ingredient of the trial medication
- •Participation in another clinical trial during or within 6 months prior to this clinical trial
- •medical or psychological condition, which might endanger the proper contuction of the clinical trial
- •Known drug or alcohol abuse
- •Intake of the following concomitant medication: Carbamazepin, Oxcarbazepin, diuretica (Furosemid, Torasemid), non steroidal antiphlogistics, Loperamid, antidiuretic hormone analoga (besides
研究者
相似试验
进行中（未招募）
不适用
Randomised, double-blind, placebo-controlled, monocentric phase III study on the efficacy and safety of Lidocaine 8 mg Sore Throat Lozenges in patients with moderate to severe acute sore throat not necessarily to be treated with antibiotics - Lidocaine 8 mg sore throat lozenges vs. placeboThe study will be performed in patients suffering from acute sore throat not necessarily to be treated with antibioticsEUCTR2004-005095-17-DEEngelhard Arzneimittel GmbH & Co. KG
已完成
不适用
Double-Blind, Randomized, Placebo-Controlled, Mono-Centre Pilot (Proof-of-Concept) Study to Investigate the Effect of IMPP-1 on Immune Functions That Contribute to Resistance to (Respiratory) Infection in Healthy SubjectsHealthy SubjectsDRKS00010568Chief Executive Officer, NutriLeads B.V.60
已完成
不适用
Influence of Silexan on pharmacokinetics and hormonal activity in females taking oral contraceptivesPharmacokinetics of ethinyl estradiol and levonorgestrelISRCTN52706881Dr. Willmar Schwabe GmbH & Co. KG (Germany)24
进行中（未招募）
不适用
Clinical trial to evaluate the relapse prevention of a hypericum extract in patients with major depressioModerate depressive episodesEUCTR2008-001417-26-DESteigerwald Arzneimittelwerk GmbH
已完成
不适用
Double-blind, placebo-controlled, randomised, clinical trial of eicosapentaenoic acid in the treatment of mood disorders among middle-aged womeDepressionISRCTN69617477Foundation Lucie et André Chagnon (Canada)144